|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
WO2000025752A1
(en)
*
|
1998-11-02 |
2000-05-11 |
Church, Marla, J. |
Multiparticulate modified release composition
|
|
JP2002532406A
(ja)
*
|
1998-12-17 |
2002-10-02 |
アルザ・コーポレーション |
複合コーティングによる液体充填ゼラチンカプセルの放出制御システムへの変換
|
|
JP2003516345A
(ja)
*
|
1999-12-09 |
2003-05-13 |
アルザ・コーポレーション |
抗ウイルス剤
|
|
AR026148A1
(es)
*
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
|
AU2002355686B2
(en)
*
|
2001-07-04 |
2007-11-29 |
Sun Pharmaceutical Industries Limited |
Gastric retention controlled drug delivery system
|
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
|
CN1606432A
(zh)
*
|
2001-12-19 |
2005-04-13 |
阿尔扎公司 |
用于增加亲水性大分子的口服生物利用度的制剂和剂型
|
|
US20030232078A1
(en)
*
|
2001-12-19 |
2003-12-18 |
Dong Liang C. |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
|
ES2295642T3
(es)
*
|
2002-06-26 |
2008-04-16 |
Intarcia Therapeutics, Inc. |
Piston de volumen eficaz de ocupacion minima para sistemas de administracion de medicamentos.
|
|
TW200414900A
(es)
*
|
2002-06-28 |
2004-08-16 |
|
|
|
JP2005533084A
(ja)
*
|
2002-06-28 |
2005-11-04 |
アルザ・コーポレーシヨン |
液体の有効成分の製剤を含んでなりかつ膨張可能な浸透圧組成物によりその放出を制御する経口の投薬形態
|
|
WO2004010981A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Methods and dosage forms for controlled delivery of paliperidone
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
NZ538939A
(en)
*
|
2002-10-21 |
2008-03-28 |
Givaudan Sa |
Controlled release pesticidal composition of an essential oil having pesticidal, antimicrobial and/or fungicidal properties
|
|
WO2004041246A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Alza Corporation |
Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs
|
|
KR20050083874A
(ko)
*
|
2002-10-31 |
2005-08-26 |
알자 코포레이션 |
액상 제제의 방출을 증진시키는 제형
|
|
US7988993B2
(en)
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20040131672A1
(en)
*
|
2003-01-07 |
2004-07-08 |
Nilobon Podhipleux |
Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
JP5229768B2
(ja)
|
2003-06-26 |
2013-07-03 |
シヴィダ・ユーエス・インコーポレイテッド |
Ｉｎ−Ｓｉｔｕゲル化薬物輸送システム
|
|
CA2530113C
(en)
|
2003-06-26 |
2013-08-13 |
Control Delivery Systems, Inc. |
Bioerodible sustained release drug delivery systems
|
|
SI1635787T1
(sl)
*
|
2003-06-26 |
2012-04-30 |
Psivida Inc |
Bioeredibilni sistemi za oddajanje zdravil z zadrževanim sproščanjem
|
|
US20050003070A1
(en)
*
|
2003-07-03 |
2005-01-06 |
Foster David V. |
Shelf stable vitamin C in oatmeal products
|
|
RS20060009A
(en)
*
|
2003-07-11 |
2008-06-05 |
F.Hoffmann-La Roche Ag., |
Saquinavir mesylate oral dosage form
|
|
PT2279729T
(pt)
*
|
2003-07-17 |
2016-09-22 |
Banner Life Sciences Llc |
Preparações de libertação controlada
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
TW200518790A
(en)
*
|
2003-07-31 |
2005-06-16 |
Alza Corp |
Osmotic engine & dosage form for controlled release of a liquid active agent formulation
|
|
JP2007521231A
(ja)
*
|
2003-08-08 |
2007-08-02 |
バイオヴェイル ラボラトリーズ インコーポレイテッド |
塩酸ブプロピオンの放出調節錠剤
|
|
US20050260268A1
(en)
*
|
2003-09-26 |
2005-11-24 |
Modi Nishit B |
Methods and dosage forms for controlled delivery of alprazolam
|
|
US20050158383A1
(en)
*
|
2003-10-21 |
2005-07-21 |
Garth Boehm |
Quetiapine formulations
|
|
CN1905857A
(zh)
*
|
2003-11-14 |
2007-01-31 |
阿尔扎公司 |
液体剂型的托吡酯的受控释放
|
|
US20050181049A1
(en)
*
|
2003-11-19 |
2005-08-18 |
Dong Liang C. |
Composition and method for enhancing bioavailability
|
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
EP1593376A1
(en)
*
|
2004-05-04 |
2005-11-09 |
Warner-Lambert Company LLC |
Improved pullulan capsules
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
WO2006058059A2
(en)
|
2004-11-23 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
|
|
CA2588296A1
(en)
|
2004-11-24 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
|
US20060121112A1
(en)
*
|
2004-12-08 |
2006-06-08 |
Elan Corporation, Plc |
Topiramate pharmaceutical composition
|
|
US20090292013A1
(en)
*
|
2004-12-14 |
2009-11-26 |
Caroline Sautter |
In-Situ Forming Implant for Animals
|
|
ATE413864T1
(de)
*
|
2005-01-27 |
2008-11-15 |
Alza Corp |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
BRPI0607017B8
(pt)
|
2005-04-06 |
2021-05-25 |
Adamas Pharmaceuticals Inc |
composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
|
|
CN101232868A
(zh)
*
|
2005-04-19 |
2008-07-30 |
阿尔扎公司 |
曲马多和加巴喷丁的控释递药剂型
|
|
US20100136106A1
(en)
*
|
2005-06-08 |
2010-06-03 |
Gary Liversidge |
Modified Release Famciclovir Compositions
|
|
AR055099A1
(es)
*
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
|
US20070082046A1
(en)
*
|
2005-10-11 |
2007-04-12 |
Banner Pharmacaps, Inc. |
Enteric valproic acid
|
|
CA2624897C
(en)
*
|
2005-10-12 |
2017-02-14 |
Proventiv Therapeutics, Llc |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
|
EP1948183B1
(en)
*
|
2005-10-13 |
2013-12-18 |
Duke University |
Compositions for the treatment and prevention of heart disease and methods of using same
|
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
|
US20070092559A1
(en)
*
|
2005-10-24 |
2007-04-26 |
Jinghua Yuan |
Liquid dosage forms having enteric properties of delayed and then sustained release
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
CA2882048C
(en)
|
2006-02-03 |
2020-03-24 |
Proventiv Therapeutics, Llc |
Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
|
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
|
JP5143131B2
(ja)
|
2006-05-30 |
2013-02-13 |
インターシア セラピューティクス，インコーポレイティド |
浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
|
|
US20070281008A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Lin Shun Y |
Personal lubricant compositions and kits for providing personal lubrication
|
|
DK3357496T3
(da)
|
2006-06-21 |
2020-05-11 |
Opko Ireland Global Holdings Ltd |
Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
|
|
DE102006032427A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
DE102006032426A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
US20080038334A1
(en)
*
|
2006-08-08 |
2008-02-14 |
John Zazula |
Method for producing and a system for cooling a hot-filled softgel capsule
|
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
|
WO2008093554A1
(ja)
*
|
2007-01-30 |
2008-08-07 |
Olympus Medical Systems Corp. |
管腔通過確認装置および管腔通過確認装置の製造方法
|
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
|
DK2148661T3
(da)
|
2007-04-25 |
2013-03-25 |
Cytochroma Inc |
Orale præparater med kontrolleret afgivelse omfattende vitamin D-forbindelse og voksagtig bærer
|
|
CA2684778C
(en)
|
2007-04-25 |
2017-09-05 |
Cytochroma Inc. |
Methods and compounds for vitamin d therapy
|
|
CA2683628C
(en)
|
2007-04-25 |
2018-03-06 |
Cytochroma Inc. |
Method of treating vitamin d insufficiency and deficiency
|
|
JP2010525080A
(ja)
|
2007-04-25 |
2010-07-22 |
プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー |
慢性腎臓病における続発性副甲状腺機能亢進症の安全かつ効果的な治療および予防方法
|
|
AU2008262031B2
(en)
*
|
2007-06-08 |
2011-08-25 |
Boehringer Ingelheim International Gmbh |
Extended release formulation of nevirapine
|
|
ES2692437T3
(es)
*
|
2007-08-13 |
2018-12-03 |
Abuse Deterrent Pharmaceutical Llc |
Fármacos resistentes al abuso, método de uso y método de preparación
|
|
JP2011500627A
(ja)
*
|
2007-10-15 |
2011-01-06 |
グラクソ グループ リミテッド |
医薬組成物の放出のためのパネル化カプセルシェル
|
|
WO2009050193A1
(en)
*
|
2007-10-15 |
2009-04-23 |
Glaxo Group Limited |
Method and apparatus for manufacturing filled linkers
|
|
CN101827571A
(zh)
*
|
2007-10-15 |
2010-09-08 |
葛兰素集团有限公司 |
用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
|
|
US20090110724A1
(en)
*
|
2007-10-31 |
2009-04-30 |
Everett Laboratories, Inc. |
Compositions and methods for treatment of pain
|
|
TWI448301B
(zh)
*
|
2007-11-05 |
2014-08-11 |
Ala Wai Pharma Inc |
用於增強經口投與之極性劑的生物可用性之調配物
|
|
US9138430B2
(en)
*
|
2007-12-27 |
2015-09-22 |
Mylan Specialty L.P. |
Formulation and method for the release of paroxetine in the large intestine
|
|
MX2010007207A
(es)
|
2007-12-28 |
2011-02-23 |
Impax Laboratories Inc |
Formulaciones de liberacion controlada de levodopa y usos de las mismas.
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
EP3112476B1
(en)
|
2008-04-02 |
2023-08-02 |
EirGen Pharma Ltd. |
Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
|
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
|
WO2010118232A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Elan Pharma International Limited |
Controlled-release clozapine compositions
|
|
HUE048542T2
(hu)
|
2009-06-16 |
2020-08-28 |
Pfizer |
Apixaban adagolási formái
|
|
WO2011006066A1
(en)
|
2009-07-10 |
2011-01-13 |
Ironwood Pharmaceuticals, Inc. |
Cb receptor agonists
|
|
CN101596174B
(zh)
*
|
2009-07-13 |
2011-04-06 |
北京航洋胶囊技术有限公司 |
一种软胶囊及其制备方法
|
|
NZ598686A
(en)
|
2009-09-28 |
2014-05-30 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
AU2010300475A1
(en)
|
2009-09-30 |
2012-05-03 |
The Regents Of The University Of California |
Cofactors and methods for use for individuals
|
|
AU2010308021A1
(en)
|
2009-10-16 |
2012-05-17 |
Ranbaxy Laboratories Limited |
Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
|
|
CN106389381A
(zh)
|
2009-12-02 |
2017-02-15 |
阿达玛斯医药公司 |
金刚烷胺组合物及其使用方法
|
|
BR112012017756A2
(pt)
|
2009-12-23 |
2016-04-19 |
Ironwood Pharmaceuticals Inc |
moduladores crth2
|
|
WO2011100324A1
(en)
|
2010-02-09 |
2011-08-18 |
Ironwood Pharmaceuticals Inc. |
Cannabinoid receptor agonists
|
|
US20130178453A1
(en)
|
2010-02-09 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid Agonists
|
|
US20130178475A1
(en)
|
2010-03-17 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
|
US8486013B2
(en)
*
|
2010-03-18 |
2013-07-16 |
Biotronik Ag |
Balloon catheter having coating
|
|
WO2011123476A1
(en)
|
2010-03-29 |
2011-10-06 |
Cytochroma Inc. |
Methods and compositions for reducing parathyroid levels
|
|
MX339805B
(es)
|
2010-04-22 |
2016-06-10 |
Intra-Cellular Therapies Inc |
Compuestos organicos.
|
|
WO2011161666A2
(en)
*
|
2010-06-21 |
2011-12-29 |
White Innovation Ltd. |
Enclosed liquid capsules
|
|
MX2012015252A
(es)
|
2010-06-30 |
2013-05-30 |
Ironwood Pharmaceuticals Inc |
Estimuladores de sgc.
|
|
WO2012009137A1
(en)
|
2010-07-12 |
2012-01-19 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
US20130259830A1
(en)
|
2010-07-12 |
2013-10-03 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
RU2016101964A
(ru)
|
2010-11-09 |
2018-11-21 |
Айронвуд Фармасьютикалз, Инк. |
СТИМУЛЯТОРЫ sGC
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
WO2013012760A1
(en)
|
2011-07-15 |
2013-01-24 |
Numeta Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
|
TWI615155B
(zh)
*
|
2011-11-01 |
2018-02-21 |
拜耳股份有限公司 |
滲透活性的陰道遞送系統
|
|
CA2861804C
(en)
|
2011-12-27 |
2021-10-26 |
Ironwood Pharmaceuticals, Inc. |
2-benzyl,3(pyrimidin-2-yl)substituted pyrazoles useful as sgc stimulators
|
|
CN103211797B
(zh)
*
|
2012-01-18 |
2017-06-06 |
北京天衡医院管理有限公司 |
盐酸维拉帕米膜控缓释微丸胶囊
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
WO2013155422A1
(en)
|
2012-04-12 |
2013-10-17 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
|
US9428506B2
(en)
|
2012-04-14 |
2016-08-30 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
|
|
US9661844B2
(en)
*
|
2012-04-30 |
2017-05-30 |
Dow Agrosciences Llc |
Pesticide composition delivery vehicles
|
|
CN104487058A
(zh)
*
|
2012-07-23 |
2015-04-01 |
三星精密化学株式会社 |
用于制备硬胶囊的含水组合物、其制备方法、硬胶囊及用于回收硬胶囊废料的方法
|
|
US9309235B2
(en)
|
2012-09-18 |
2016-04-12 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
|
US9487508B2
(en)
|
2012-09-19 |
2016-11-08 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
|
CN104918610B
(zh)
|
2012-11-13 |
2018-04-10 |
纽斯尔特科学公司 |
用于增强能量代谢的组合物和方法
|
|
JP2016505023A
(ja)
|
2013-01-15 |
2016-02-18 |
ニューサート サイエンシーズ， インコーポレイテッド |
肺の状態の処置
|
|
GB201303781D0
(en)
|
2013-03-04 |
2013-04-17 |
Gauthier Pierre Pascal |
Oral timer device and method of using same
|
|
EP2968320B1
(en)
|
2013-03-15 |
2020-11-11 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 ｄ 방출 제형
|
|
US20140275038A1
(en)
|
2013-03-15 |
2014-09-18 |
Inspirion Delivery Technologies, Llc |
Abuse deterrent compositions and methods of use
|
|
RU2015143836A
(ru)
|
2013-03-15 |
2017-04-27 |
Нусерт Сайенсиз, Инк. |
Лейцин и никотиновая кислота для снижения уровня липидов
|
|
EP3998260B1
(en)
|
2013-03-15 |
2023-11-01 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
|
CN103315973B
(zh)
*
|
2013-05-24 |
2014-05-07 |
杭州和正医药有限公司 |
喹硫平的渗透泵型控释制剂
|
|
WO2014204933A1
(en)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
|
EP2839853A1
(de)
*
|
2013-08-23 |
2015-02-25 |
LTS LOHMANN Therapie-Systeme AG |
Transdermales therapeutisches System mit Druckerzeugungsvorrichtung
|
|
PL3054929T3
(pl)
|
2013-10-07 |
2021-05-31 |
Impax Laboratories, Llc |
Mukoadhezyjne preparaty lewodopy i / lub estrów lewodopy o kontrolowanym uwalnianiu oraz ich zastosowania
|
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
HUE056496T2
(hu)
|
2013-12-03 |
2022-02-28 |
Intra Cellular Therapies Inc |
Eljárás skizofrénia reziduális szimptómáinak kezelésére
|
|
EA032028B1
(ru)
|
2013-12-11 |
2019-03-29 |
Айронвуд Фармасьютикалз, Инк. |
СТИМУЛЯТОРЫ рГЦ
|
|
KR102199596B1
(ko)
*
|
2013-12-31 |
2021-01-07 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
KR102161001B1
(ko)
*
|
2013-12-31 |
2020-09-29 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
KR20160119863A
(ko)
|
2014-02-27 |
2016-10-14 |
뉴서트 사이언시스, 인크. |
간 지방증의 감소 또는 예방을 위한 조성물 및 방법
|
|
MX365969B
(es)
|
2014-04-04 |
2019-06-21 |
Intra Cellular Therapies Inc |
Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
|
|
CA2944755A1
(en)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10179776B2
(en)
|
2014-06-09 |
2019-01-15 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
SG10201911274TA
(en)
|
2014-08-07 |
2020-02-27 |
Opko Ireland Global Holdings Ltd |
Adjunctive therapy with 25-hydroxyvitamin d
|
|
US10729685B2
(en)
|
2014-09-15 |
2020-08-04 |
Ohemo Life Sciences Inc. |
Orally administrable compositions and methods of deterring abuse by intranasal administration
|
|
US20170298055A1
(en)
|
2014-09-17 |
2017-10-19 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
|
US20170291889A1
(en)
|
2014-09-17 |
2017-10-12 |
Ironwood Pharmaceuticals, Inc. |
Pyrazole derivatives as sgc stimulators
|
|
CN107406421A
(zh)
|
2014-09-17 |
2017-11-28 |
铁木医药有限公司 |
sGC刺激物
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US9808608B2
(en)
*
|
2014-11-16 |
2017-11-07 |
International Business Machines Corporation |
Helical coil delivery device for active agent
|
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
US20170119680A1
(en)
|
2015-10-30 |
2017-05-04 |
R.P. Scherer Technologies, Llc |
Extended release film-coated capsules
|
|
EP3397253A1
(en)
|
2015-12-30 |
2018-11-07 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
AU2017211791B2
(en)
|
2016-01-26 |
2022-01-06 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
MX2018011676A
(es)
|
2016-03-25 |
2018-12-19 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
KR20180123100A
(ko)
|
2016-03-28 |
2018-11-14 |
옵코 아일랜드 글로벌 홀딩스 리미티드 |
비타민 d 치료 방법
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
CN109310743A
(zh)
|
2016-05-16 |
2019-02-05 |
因塔西亚制药公司 |
胰高血糖素受体选择性多肽及其使用方法
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
US20200197315A1
(en)
*
|
2016-07-06 |
2020-06-25 |
Durect Corporation |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
PT3507291T
(pt)
|
2016-09-02 |
2021-08-30 |
Cyclerion Therapeutics Inc |
Estimulantes de sgc bicíclicos fundidos
|
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
|
IL266275B2
(en)
|
2016-11-08 |
2023-12-01 |
Cyclerion Therapeutics Inc |
Treatment of CNS diseases by SGC stimulators
|
|
CA3042713A1
(en)
|
2016-11-08 |
2018-05-17 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
|
WO2018126143A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2018126140A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP3565580B1
(en)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
|
|
MX2021013640A
(es)
|
2017-03-24 |
2022-08-31 |
Intra Cellular Therapies Inc |
Composiciones novedosas y metodos.
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
US11376249B2
(en)
|
2017-07-26 |
2022-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
CA3094949A1
(en)
|
2018-03-23 |
2019-09-26 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
CN111989158B
(zh)
*
|
2018-04-15 |
2022-08-12 |
奥普图弗卢迪克生物鉴定有限责任公司 |
压差辅助排水系统
|
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
US11957791B2
(en)
|
2018-08-31 |
2024-04-16 |
Intra-Cellular Therapies, Inc. |
Methods
|
|
EP3843739A4
(en)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NEW METHODS
|
|
US10940088B1
(en)
*
|
2020-01-09 |
2021-03-09 |
King Saud University |
Method of preparing low dose pharmaceutical formulations
|
|
CN112641751B
(zh)
*
|
2020-09-25 |
2022-06-21 |
广州玖洲胶囊生物科技有限公司 |
一种羟丙甲基纤维素和卡拉胶的填充空心充液胶囊
|